Company Filing History:
Years Active: 2012
Title: The Innovations of Micheline Lambermont
Introduction
Micheline Lambermont is a notable inventor based in Waterloo, Belgium. She has made significant contributions to the field of biomedical research, particularly in the area of stem cell therapy. Her innovative work has led to the development of methods that enhance the differentiation of bone marrow stem cells.
Latest Patents
Micheline Lambermont holds a patent for a "Method for osteogenic differentiation of bone marrow stem cells (BMSC) and uses thereof." This patent discloses methods for obtaining osteoprogenitors, osteoblasts, or osteoblast phenotype cells from human bone marrow stem cells in vitro or ex vivo. The process involves contacting bone marrow stem cells with human serum or plasma and a growth factor or a biologically active variant or derivative thereof. The patent also provides cell populations that may include additional cell types, such as endothelial cells or progenitors. The osteoprogenitors, osteoblasts, or osteoblast phenotype cells developed through this method can be utilized in therapeutic applications, particularly in bone therapy.
Career Highlights
Throughout her career, Micheline has worked with esteemed institutions, including Université Libre de Bruxelles. Her research has focused on advancing the understanding and application of stem cell technology in medicine.
Collaborations
Micheline has collaborated with notable colleagues such as Dominique Egrise and Valerie Gangji, contributing to the advancement of her research and innovations in the field.
Conclusion
Micheline Lambermont's contributions to stem cell research and therapy highlight her role as an influential inventor in the biomedical field. Her patented methods for osteogenic differentiation of bone marrow stem cells represent a significant advancement in therapeutic applications.